Company / Current Assets per Share
Regeneron Pharmaceuticals Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$158.50
FY2025
5-year range
$122.29 / $173.61
FY2021-FY2025
Trend
-3.6%
vs FY2024
Sector context
#4 of 210
Health Care
What the data says
Among 210 Health Care companies, Regeneron Pharmaceuticals is in the top 2% for current assets per share. Declined from $173.61 to $158.50 over the past 2 years.
Based on SEC 10-K filings.
158.50 in FY2025 with a 5-year CAGR of +13.2%. Top quartile in the Health Care sector.
Declined from $173.61 to $158.50 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +4.7%
- 5-Year CAGR
- +13.2%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 210This company $158.50 Sector average $170.65
▼
-7.1% below sector average
Key checks
Key Insights
- In FY2025, current assets per share decreased 3.6% year-over-year.
- Ranks #4 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2023.
- Lowest current assets per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.03 (safe zone, above 2.9 threshold)
- Strong profit margin: 32.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $158.50 | -3.6% |
| FY2024 | $164.41 | -5.3% |
| FY2023 | $173.61 | +25.8% |
| FY2022 | $138.00 | +12.8% |
| FY2021 | $122.29 | +43.6% |
| FY2020 | $85.18 | +28.4% |
| FY2019 | $66.34 | +19.7% |
| FY2018 | $55.44 | +47.4% |
| FY2017 | $37.62 | +34.2% |
| FY2016 | $28.04 | +7.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026